Post_ID,Ticker,Title,Body,Post_Date,Upvotes,Num_Comments
1hlawd6_LRCX,LRCX,Avoiding LRCX in 2025.,The opportunity cost of holding LRCX is too great. Yesterday was a nice green day to sell off and exit before red days arrive again. Iâ€™m expecting more China ban restriction threats in 2025 under Trump,2024-12-24,0,8
1hlawd6_KLAC,KLAC,Avoiding LRCX in 2025.,,2024-12-24,0,8
1hhkep0_LRCX,LRCX,Who still â¤ï¸ LRCX and ASML?,Not even my SOUN gains could make up for the LRCX losses. It was a big mistake to buy LRCX at $96 in June after seeing analysts' average price target at $110. These analysts are a load of contradictory nonsense. It dropped as fast as lightning but then climbing back up like a snail. I will never look at LRCX or ASML ever again once I sell my LRCX at a loss and redeploy the funds to SOUN. ,2024-12-19,0,7
1hhkhrc_LRCX,LRCX,Who still loves â¤ï¸ LRCX and ASML?,"Just checked analysts' average price target is $93.69, and the highest estimated is $114 with a call to BUY. They must be out of their mind!
Not even my NVDA gains could make up for the LRCX losses. It was a big mistake to buy LRCX at $96 in June after reading analysts' average price target is $110. These analysts are a load of contradictory nonsense. It dropped as fast as lightning but then climbing back up like a snail. I will never look at LRCX or ASML ever again once I sell my LRCX at a loss and redeploy the funds.",2024-12-19,0,29
1gh05kv_MSFT,MSFT,"Updated Valuations: LRCX, FSLR, MEDP, V, GOOGL, and MSFT",,2024-11-01,37,6
1gh0041_MSFT,MSFT,"Updated Valuations: LRCX, FSLR, MEDP, V, GOOGL, and MSFT",,2024-11-01,103,47
1gh05kv_LRCX,LRCX,"Updated Valuations: LRCX, FSLR, MEDP, V, GOOGL, and MSFT","In October, some companiesÂ I covered released their quarterly earnings reports. It's time to update their valuations and review the latest reports. Some explanations regarding screenshots with fair price estimates:

* I marked cells that I updatedÂ **as grey**Â (after the latest earning reports)
* Fair-to-Current Price and Current Price/Fair Price: green - undervalued, blue - fairly valued, yellow - overvalued
* Some Future EPS Growth marked as green means that the projected earnings growth is even higher; 20% is my maximum

# Lam Research (LRCX): Undervalued ðŸŸ¢

https://preview.redd.it/7kp5t0cfv8yd1.png?width=1814&format=png&auto=webp&s=bc4410f8735c6097662ca57497c2cb9dbdf5e95b

# ðŸ‘ Positive Points

* Lam Research posted a strong September quarter with revenues and earnings per share exceeding the midpoint of guidance.
* The company achieved its fifth consecutive quarter of revenue growth, indicating strong execution despite a challenging industry environment.
* LRCX is well-positioned to benefit from technology upgrades in NAND, which is expected to drive spending recovery.
* The company is seeing strong momentum in advanced packaging, with SABRE 3D revenue more than doubling this year.
* LRCX is experiencing strong customer demand for productivity enhancements and equipment intelligence services, with increased adoption of its offerings.

# ðŸ‘Ž Negative Points

* Domestic China WFE is expected to decline in the second half of the year, impacting LRCX's revenue from the region.
* Gross margin decreased slightly due to a decline in customer mix and increased incentive compensation.
* Operating expenses increased due to higher program spending and incentive compensation, impacting profitability.
* The NAND segment has experienced a prolonged down cycle, with spending expected to increase only in 2025.
* Lam Research anticipates a headwind in customer mix affecting gross margins due to a lower percentage of revenue from China.

# First Solar (FSLR): Undervalued ðŸŸ¢

https://preview.redd.it/8vghzbngv8yd1.png?width=1950&format=png&auto=webp&s=b1290e0e35e24a050565242df87c948d6bed7bc3

# ðŸ‘ Positive Points

* First Solar achieved a record quarterly production of 3.8 gigawatts, demonstrating strong manufacturing capabilities.
* The company inaugurated a new $1.1 billion Alabama facility, adding 3.5 gigawatts of solar manufacturing capacity, with plans for further expansion in Louisiana.
* First Solar has a robust contracted backlog of 73.3 gigawatts, providing long-term revenue visibility.
* The company is launching CuRe production, aiming to enhance its technology offerings and capture additional revenue through contractual adjusters.
* First Solar was recognized by MIT Technology Review and Time Magazine for its leadership in solar technology and innovation.

# ðŸ‘Ž Negative Points

* FSLR faced a $50 million product warranty charge due to manufacturing issues with its Series 7 product.
* The company experienced operational challenges, including hurricanes and logistical disruptions, impacting financial performance.
* There is ongoing pressure from Chinese dumping in the Indian market, leading to depressed ASPs and strategic shifts in production.
* First Solar had to terminate a contract with Plug Power due to project delays, impacting its bookings.
* The company is facing intellectual property challenges within the solar manufacturing sector, particularly related to TOPCon patents.

# Medpace (MEDP): Undervalued ðŸŸ¢

https://preview.redd.it/w0v7gqhiv8yd1.png?width=1928&format=png&auto=webp&s=37321c0516d27c5669e29d0b58d3ac5c8d5c021b

# ðŸ‘ Positive Points

* Revenue for the third quarter of 2024 was $533.3 million, representing a year-over-year increase of 8.3%.
* EBITDA for the third quarter increased by 31.7% compared to the same period in 2023, reaching $118.8 million.
* Net income for the third quarter rose by 36.7% year-over-year, driven by interest income and partially offset by a higher effective tax rate.
* Ending backlog as of September 30, 2024, was approximately $2.9 billion, an increase of 8.8% from the prior year.
* The company expects to convert approximately $1.62 billion of backlog into revenue over the next 12 months, indicating strong future revenue potential.

# ðŸ‘Ž Negative Points

* Backlog cancellations in Q3 were above the usual range, marking three consecutive quarters of elevated cancellations.
* Net new business awards decreased by 12.7% from the prior year, resulting in a net book-to-bill ratio of 1.0 for the quarter.
* The elevated cancellations are expected to depress reported net backlog awards in Q4 and Q1 of 2025.
* RFPs were down modestly on a year-over-year and sequential basis, indicating a potential slowdown in new business opportunities.
* Gross bookings were lower in the quarter due to prior cancellations, impacting the overall business momentum.

# Visa (V): Undervalued ðŸŸ¢

https://preview.redd.it/dsyw4poev8yd1.png?width=1799&format=png&auto=webp&s=b5e0a7c43b27f01308a01bc0f7a6c7de524a3a62

# ðŸ‘ Positive Points

* Visa reported strong financial results for the fourth quarter, with net revenue of $9.6 billion, up 12% year-over-year, and EPS up 16%.
* The company saw significant growth in cross-border volume, excluding intra-Europe, which rose 13%, and processed transactions grew 10% year-over-year.
* Visa continues to expand its consumer payments business, with over 4.6 billion credentials, up 7% year-over-year, and 11.5 billion \[tok\]-ens, with more than 30% of total transactions \[tok\]-enized.
* The company has made significant strides in new flows, with revenue growing 22% year-over-year in constant dollars, and Visa Direct transactions increasing by 38%.
* Visa has successfully renewed and expanded several key partnerships globally, including agreements with major clients like Grupo Pramerica, SMCC, Alrajhi, and Standard Chartered Bank.

# ðŸ‘Ž Negative Points

* Visa faces regulatory challenges, including a lawsuit by the Department of Justice, which the company believes is meritless.
* The company experienced slower growth in Asia Pacific payments volume, primarily due to macroeconomic conditions, particularly in Mainland China.
* Cross-border travel volume growth was lower than expected, mainly due to challenges in Asia Pacific travel corridors.
* Visa anticipates a significant increase in client incentives in fiscal 2025, which could impact net revenue growth.
* The company expects a step down in adjusted net revenue growth from Q4 2024 to Q1 2025 due to various factors, including increased incentives and the timing of pricing actions.

# Alphabet (GOOGL): Undervalued ðŸŸ¢

https://preview.redd.it/0pj3vjtkv8yd1.png?width=1837&format=png&auto=webp&s=c27b4fb79b69876583b0e1f112fc573d4833bddb

# ðŸ‘ Positive Points

* Alphabet reported a 15% increase in consolidated revenue, with Google Cloud revenue growing by 35% year-over-year.
* The company has made significant advancements in AI, with the Gemini models being integrated across all major products and platforms, reaching over 1 billion users.
* YouTube's combined ad and subscription revenue surpassed $50 billion over the past four quarters, driven by strong growth in YouTube TV, NFL Sunday Ticket, and YouTube Music Premium.
* Alphabet is making substantial investments in clean energy, including a corporate agreement to purchase nuclear energy, supporting its commitment to sustainability.
* The company is seeing strong engagement and increased search usage with the rollout of AI Overviews to over 100 new countries and territories.

# ðŸ‘Ž Negative Points

* Network advertising revenue declined by 2% year-over-year, indicating challenges in this segment.
* The company faces potential legal challenges from the DOJ, which could impact its search agreements with partners like Apple.
* Alphabet is experiencing increased costs, with total cost of revenue up by 10% and operating expenses rising by 5%.
* There is a headwind to year-over-year growth in subscription platforms and devices revenue due to the pull forward of Made by Google launches.
* The company is facing increased competition in the AI space, with a need to continuously innovate to maintain its leadership position.

# Microsoft (MSFT): Fairly Valued ðŸ”µ

https://preview.redd.it/wof2io3nv8yd1.png?width=1811&format=png&auto=webp&s=37e60a6c8dd7487b3a300d95a41e24c300a3338e

# ðŸ‘ Positive Points

* Microsoft Cloud revenue surpassed $38.9 billion, marking a 22% increase, driven by strong demand for AI and cloud services.
* AI business is on track to surpass an annual revenue run rate of $10 billion next quarter, making it the fastest-growing business in Microsoft's history.
* Azure and other cloud services revenue grew 33% in constant currency, with healthy consumption trends.
* Microsoft 365 Copilot adoption is accelerating, with nearly 70% of the Fortune 500 using it, and customers continue to adopt it at a faster rate than any other new Microsoft 365 suite.
* LinkedIn revenue increased 10%, with record engagement and growth across all lines of business.

# ðŸ‘Ž Negative Points

* Microsoft Cloud gross margin percentage decreased by 2 points year over year, driven by scaling AI infrastructure.
* Operating expenses increased by 12%, partly due to the Activision acquisition, impacting overall profitability.
* Free cash flow decreased by 7% year over year, reflecting higher capital expenditures to support cloud and AI offerings.
* Supply constraints, particularly in AI infrastructure, are impacting Azure's ability to meet demand, leading to potential growth deceleration.
* The Activision acquisition had a negative $0.05 impact on earnings per share due to purchase accounting adjustments and related costs.",2024-11-01,38,6
1gh0041_LRCX,LRCX,"Updated Valuations: LRCX, FSLR, MEDP, V, GOOGL, and MSFT","In October, some companiesÂ I covered released their quarterly earnings reports. It's time to update their valuations and review the latest reports. Some explanations regarding screenshots with fair price estimates:

* I marked cells that I updatedÂ **as grey**Â (after the latest earning reports)
* Fair-to-Current Price and Current Price/Fair Price: green - undervalued, blue - fairly valued, yellow - overvalued
* Some Future EPS Growth marked as green means that the projected earnings growth is even higher; 20% is my maximum

# Lam Research (LRCX): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F765e93e7-9a15-4dfd-8941-4ff521d702ae_1814x935.png)

# ðŸ‘ Positive Points

* Lam Research posted a strong September quarter with revenues and earnings per share exceeding the midpoint of guidance.
* The company achieved its fifth consecutive quarter of revenue growth, indicating strong execution despite a challenging industry environment.
* LRCX is well-positioned to benefit from technology upgrades in NAND, which is expected to drive spending recovery.
* The company is seeing strong momentum in advanced packaging, with SABRE 3D revenue more than doubling this year.
* LRCX is experiencing strong customer demand for productivity enhancements and equipment intelligence services, with increased adoption of its offerings.

# ðŸ‘Ž Negative Points

* Domestic China WFE is expected to decline in the second half of the year, impacting LRCX's revenue from the region.
* Gross margin decreased slightly due to a decline in customer mix and increased incentive compensation.
* Operating expenses increased due to higher program spending and incentive compensation, impacting profitability.
* The NAND segment has experienced a prolonged down cycle, with spending expected to increase only in 2025.
* Lam Research anticipates a headwind in customer mix affecting gross margins due to a lower percentage of revenue from China.

# First Solar (FSLR): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F173d92b6-85d1-4bf3-84c5-e0716430968c_1950x936.png)

# ðŸ‘ Positive Points

* First Solar achieved a record quarterly production of 3.8 gigawatts, demonstrating strong manufacturing capabilities.
* The company inaugurated a new $1.1 billion Alabama facility, adding 3.5 gigawatts of solar manufacturing capacity, with plans for further expansion in Louisiana.
* First Solar has a robust contracted backlog of 73.3 gigawatts, providing long-term revenue visibility.
* The company is launching CuRe production, aiming to enhance its technology offerings and capture additional revenue through contractual adjusters.
* First Solar was recognized by MIT Technology Review and Time Magazine for its leadership in solar technology and innovation.

# ðŸ‘Ž Negative Points

* FSLR faced a $50 million product warranty charge due to manufacturing issues with its Series 7 product.
* The company experienced operational challenges, including hurricanes and logistical disruptions, impacting financial performance.
* There is ongoing pressure from Chinese dumping in the Indian market, leading to depressed ASPs and strategic shifts in production.
* First Solar had to terminate a contract with Plug Power due to project delays, impacting its bookings.
* The company is facing intellectual property challenges within the solar manufacturing sector, particularly related to TOPCon patents.

# Medpace (MEDP): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fdf8268c6-080b-48c0-a735-59cbf582ce11_1928x942.png)

# ðŸ‘ Positive Points

* Revenue for the third quarter of 2024 was $533.3 million, representing a year-over-year increase of 8.3%.
* EBITDA for the third quarter increased by 31.7% compared to the same period in 2023, reaching $118.8 million.
* Net income for the third quarter rose by 36.7% year-over-year, driven by interest income and partially offset by a higher effective tax rate.
* Ending backlog as of September 30, 2024, was approximately $2.9 billion, an increase of 8.8% from the prior year.
* The company expects to convert approximately $1.62 billion of backlog into revenue over the next 12 months, indicating strong future revenue potential.

# ðŸ‘Ž Negative Points

* Backlog cancellations in Q3 were above the usual range, marking three consecutive quarters of elevated cancellations.
* Net new business awards decreased by 12.7% from the prior year, resulting in a net book-to-bill ratio of 1.0 for the quarter.
* The elevated cancellations are expected to depress reported net backlog awards in Q4 and Q1 of 2025.
* RFPs were down modestly on a year-over-year and sequential basis, indicating a potential slowdown in new business opportunities.
* Gross bookings were lower in the quarter due to prior cancellations, impacting the overall business momentum.

# Visa (V): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F379759e2-9697-4734-b89a-f31f8ed60eb8_1799x927.png)

# ðŸ‘ Positive Points

* Visa reported strong financial results for the fourth quarter, with net revenue of $9.6 billion, up 12% year-over-year, and EPS up 16%.
* The company saw significant growth in cross-border volume, excluding intra-Europe, which rose 13%, and processed transactions grew 10% year-over-year.
* Visa continues to expand its consumer payments business, with over 4.6 billion credentials, up 7% year-over-year, and 11.5 billion tokens, with more than 30% of total transactions tokenized.
* The company has made significant strides in new flows, with revenue growing 22% year-over-year in constant dollars, and Visa Direct transactions increasing by 38%.
* Visa has successfully renewed and expanded several key partnerships globally, including agreements with major clients like Grupo Pramerica, SMCC, Alrajhi, and Standard Chartered Bank.

# ðŸ‘Ž Negative Points

* Visa faces regulatory challenges, including a lawsuit by the Department of Justice, which the company believes is meritless.
* The company experienced slower growth in Asia Pacific payments volume, primarily due to macroeconomic conditions, particularly in Mainland China.
* Cross-border travel volume growth was lower than expected, mainly due to challenges in Asia Pacific travel corridors.
* Visa anticipates a significant increase in client incentives in fiscal 2025, which could impact net revenue growth.
* The company expects a step down in adjusted net revenue growth from Q4 2024 to Q1 2025 due to various factors, including increased incentives and the timing of pricing actions.

# Alphabet (GOOGL): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc9aac525-db12-4b3d-8188-e7893e29a638_1837x934.png)

# ðŸ‘ Positive Points

* Alphabet reported a 15% increase in consolidated revenue, with Google Cloud revenue growing by 35% year-over-year.
* The company has made significant advancements in AI, with the Gemini models being integrated across all major products and platforms, reaching over 1 billion users.
* YouTube's combined ad and subscription revenue surpassed $50 billion over the past four quarters, driven by strong growth in YouTube TV, NFL Sunday Ticket, and YouTube Music Premium.
* Alphabet is making substantial investments in clean energy, including a corporate agreement to purchase nuclear energy, supporting its commitment to sustainability.
* The company is seeing strong engagement and increased search usage with the rollout of AI Overviews to over 100 new countries and territories.

# ðŸ‘Ž Negative Points

* Network advertising revenue declined by 2% year-over-year, indicating challenges in this segment.
* The company faces potential legal challenges from the DOJ, which could impact its search agreements with partners like Apple.
* Alphabet is experiencing increased costs, with total cost of revenue up by 10% and operating expenses rising by 5%.
* There is a headwind to year-over-year growth in subscription platforms and devices revenue due to the pull forward of Made by Google launches.
* The company is facing increased competition in the AI space, with a need to continuously innovate to maintain its leadership position.

# Microsoft (MSFT): Fairly Valued ðŸ”µ

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd609a767-f662-4d0e-b94e-4f8235f12e6c_1811x941.png)

# ðŸ‘ Positive Points

* Microsoft Cloud revenue surpassed $38.9 billion, marking a 22% increase, driven by strong demand for AI and cloud services.
* AI business is on track to surpass an annual revenue run rate of $10 billion next quarter, making it the fastest-growing business in Microsoft's history.
* Azure and other cloud services revenue grew 33% in constant currency, with healthy consumption trends.
* Microsoft 365 Copilot adoption is accelerating, with nearly 70% of the Fortune 500 using it, and customers continue to adopt it at a faster rate than any other new Microsoft 365 suite.
* LinkedIn revenue increased 10%, with record engagement and growth across all lines of business.

# ðŸ‘Ž Negative Points

* Microsoft Cloud gross margin percentage decreased by 2 points year over year, driven by scaling AI infrastructure.
* Operating expenses increased by 12%, partly due to the Activision acquisition, impacting overall profitability.
* Free cash flow decreased by 7% year over year, reflecting higher capital expenditures to support cloud and AI offerings.
* Supply constraints, particularly in AI infrastructure, are impacting Azure's ability to meet demand, leading to potential growth deceleration.
* The Activision acquisition had a negative $0.05 impact on earnings per share due to purchase accounting adjustments and related costs.",2024-11-01,108,47
1gh05kv_GOOGL,GOOGL,"Updated Valuations: LRCX, FSLR, MEDP, V, GOOGL, and MSFT","In October, some companiesÂ I covered released their quarterly earnings reports. It's time to update their valuations and review the latest reports. Some explanations regarding screenshots with fair price estimates:

* I marked cells that I updatedÂ **as grey**Â (after the latest earning reports)
* Fair-to-Current Price and Current Price/Fair Price: green - undervalued, blue - fairly valued, yellow - overvalued
* Some Future EPS Growth marked as green means that the projected earnings growth is even higher; 20% is my maximum

# Lam Research (LRCX): Undervalued ðŸŸ¢

https://preview.redd.it/7kp5t0cfv8yd1.png?width=1814&format=png&auto=webp&s=bc4410f8735c6097662ca57497c2cb9dbdf5e95b

# ðŸ‘ Positive Points

* Lam Research posted a strong September quarter with revenues and earnings per share exceeding the midpoint of guidance.
* The company achieved its fifth consecutive quarter of revenue growth, indicating strong execution despite a challenging industry environment.
* LRCX is well-positioned to benefit from technology upgrades in NAND, which is expected to drive spending recovery.
* The company is seeing strong momentum in advanced packaging, with SABRE 3D revenue more than doubling this year.
* LRCX is experiencing strong customer demand for productivity enhancements and equipment intelligence services, with increased adoption of its offerings.

# ðŸ‘Ž Negative Points

* Domestic China WFE is expected to decline in the second half of the year, impacting LRCX's revenue from the region.
* Gross margin decreased slightly due to a decline in customer mix and increased incentive compensation.
* Operating expenses increased due to higher program spending and incentive compensation, impacting profitability.
* The NAND segment has experienced a prolonged down cycle, with spending expected to increase only in 2025.
* Lam Research anticipates a headwind in customer mix affecting gross margins due to a lower percentage of revenue from China.

# First Solar (FSLR): Undervalued ðŸŸ¢

https://preview.redd.it/8vghzbngv8yd1.png?width=1950&format=png&auto=webp&s=b1290e0e35e24a050565242df87c948d6bed7bc3

# ðŸ‘ Positive Points

* First Solar achieved a record quarterly production of 3.8 gigawatts, demonstrating strong manufacturing capabilities.
* The company inaugurated a new $1.1 billion Alabama facility, adding 3.5 gigawatts of solar manufacturing capacity, with plans for further expansion in Louisiana.
* First Solar has a robust contracted backlog of 73.3 gigawatts, providing long-term revenue visibility.
* The company is launching CuRe production, aiming to enhance its technology offerings and capture additional revenue through contractual adjusters.
* First Solar was recognized by MIT Technology Review and Time Magazine for its leadership in solar technology and innovation.

# ðŸ‘Ž Negative Points

* FSLR faced a $50 million product warranty charge due to manufacturing issues with its Series 7 product.
* The company experienced operational challenges, including hurricanes and logistical disruptions, impacting financial performance.
* There is ongoing pressure from Chinese dumping in the Indian market, leading to depressed ASPs and strategic shifts in production.
* First Solar had to terminate a contract with Plug Power due to project delays, impacting its bookings.
* The company is facing intellectual property challenges within the solar manufacturing sector, particularly related to TOPCon patents.

# Medpace (MEDP): Undervalued ðŸŸ¢

https://preview.redd.it/w0v7gqhiv8yd1.png?width=1928&format=png&auto=webp&s=37321c0516d27c5669e29d0b58d3ac5c8d5c021b

# ðŸ‘ Positive Points

* Revenue for the third quarter of 2024 was $533.3 million, representing a year-over-year increase of 8.3%.
* EBITDA for the third quarter increased by 31.7% compared to the same period in 2023, reaching $118.8 million.
* Net income for the third quarter rose by 36.7% year-over-year, driven by interest income and partially offset by a higher effective tax rate.
* Ending backlog as of September 30, 2024, was approximately $2.9 billion, an increase of 8.8% from the prior year.
* The company expects to convert approximately $1.62 billion of backlog into revenue over the next 12 months, indicating strong future revenue potential.

# ðŸ‘Ž Negative Points

* Backlog cancellations in Q3 were above the usual range, marking three consecutive quarters of elevated cancellations.
* Net new business awards decreased by 12.7% from the prior year, resulting in a net book-to-bill ratio of 1.0 for the quarter.
* The elevated cancellations are expected to depress reported net backlog awards in Q4 and Q1 of 2025.
* RFPs were down modestly on a year-over-year and sequential basis, indicating a potential slowdown in new business opportunities.
* Gross bookings were lower in the quarter due to prior cancellations, impacting the overall business momentum.

# Visa (V): Undervalued ðŸŸ¢

https://preview.redd.it/dsyw4poev8yd1.png?width=1799&format=png&auto=webp&s=b5e0a7c43b27f01308a01bc0f7a6c7de524a3a62

# ðŸ‘ Positive Points

* Visa reported strong financial results for the fourth quarter, with net revenue of $9.6 billion, up 12% year-over-year, and EPS up 16%.
* The company saw significant growth in cross-border volume, excluding intra-Europe, which rose 13%, and processed transactions grew 10% year-over-year.
* Visa continues to expand its consumer payments business, with over 4.6 billion credentials, up 7% year-over-year, and 11.5 billion \[tok\]-ens, with more than 30% of total transactions \[tok\]-enized.
* The company has made significant strides in new flows, with revenue growing 22% year-over-year in constant dollars, and Visa Direct transactions increasing by 38%.
* Visa has successfully renewed and expanded several key partnerships globally, including agreements with major clients like Grupo Pramerica, SMCC, Alrajhi, and Standard Chartered Bank.

# ðŸ‘Ž Negative Points

* Visa faces regulatory challenges, including a lawsuit by the Department of Justice, which the company believes is meritless.
* The company experienced slower growth in Asia Pacific payments volume, primarily due to macroeconomic conditions, particularly in Mainland China.
* Cross-border travel volume growth was lower than expected, mainly due to challenges in Asia Pacific travel corridors.
* Visa anticipates a significant increase in client incentives in fiscal 2025, which could impact net revenue growth.
* The company expects a step down in adjusted net revenue growth from Q4 2024 to Q1 2025 due to various factors, including increased incentives and the timing of pricing actions.

# Alphabet (GOOGL): Undervalued ðŸŸ¢

https://preview.redd.it/0pj3vjtkv8yd1.png?width=1837&format=png&auto=webp&s=c27b4fb79b69876583b0e1f112fc573d4833bddb

# ðŸ‘ Positive Points

* Alphabet reported a 15% increase in consolidated revenue, with Google Cloud revenue growing by 35% year-over-year.
* The company has made significant advancements in AI, with the Gemini models being integrated across all major products and platforms, reaching over 1 billion users.
* YouTube's combined ad and subscription revenue surpassed $50 billion over the past four quarters, driven by strong growth in YouTube TV, NFL Sunday Ticket, and YouTube Music Premium.
* Alphabet is making substantial investments in clean energy, including a corporate agreement to purchase nuclear energy, supporting its commitment to sustainability.
* The company is seeing strong engagement and increased search usage with the rollout of AI Overviews to over 100 new countries and territories.

# ðŸ‘Ž Negative Points

* Network advertising revenue declined by 2% year-over-year, indicating challenges in this segment.
* The company faces potential legal challenges from the DOJ, which could impact its search agreements with partners like Apple.
* Alphabet is experiencing increased costs, with total cost of revenue up by 10% and operating expenses rising by 5%.
* There is a headwind to year-over-year growth in subscription platforms and devices revenue due to the pull forward of Made by Google launches.
* The company is facing increased competition in the AI space, with a need to continuously innovate to maintain its leadership position.

# Microsoft (MSFT): Fairly Valued ðŸ”µ

https://preview.redd.it/wof2io3nv8yd1.png?width=1811&format=png&auto=webp&s=37e60a6c8dd7487b3a300d95a41e24c300a3338e

# ðŸ‘ Positive Points

* Microsoft Cloud revenue surpassed $38.9 billion, marking a 22% increase, driven by strong demand for AI and cloud services.
* AI business is on track to surpass an annual revenue run rate of $10 billion next quarter, making it the fastest-growing business in Microsoft's history.
* Azure and other cloud services revenue grew 33% in constant currency, with healthy consumption trends.
* Microsoft 365 Copilot adoption is accelerating, with nearly 70% of the Fortune 500 using it, and customers continue to adopt it at a faster rate than any other new Microsoft 365 suite.
* LinkedIn revenue increased 10%, with record engagement and growth across all lines of business.

# ðŸ‘Ž Negative Points

* Microsoft Cloud gross margin percentage decreased by 2 points year over year, driven by scaling AI infrastructure.
* Operating expenses increased by 12%, partly due to the Activision acquisition, impacting overall profitability.
* Free cash flow decreased by 7% year over year, reflecting higher capital expenditures to support cloud and AI offerings.
* Supply constraints, particularly in AI infrastructure, are impacting Azure's ability to meet demand, leading to potential growth deceleration.
* The Activision acquisition had a negative $0.05 impact on earnings per share due to purchase accounting adjustments and related costs.",2024-11-01,37,6
1gh0041_GOOGL,GOOGL,"Updated Valuations: LRCX, FSLR, MEDP, V, GOOGL, and MSFT","In October, some companiesÂ I covered released their quarterly earnings reports. It's time to update their valuations and review the latest reports. Some explanations regarding screenshots with fair price estimates:

* I marked cells that I updatedÂ **as grey**Â (after the latest earning reports)
* Fair-to-Current Price and Current Price/Fair Price: green - undervalued, blue - fairly valued, yellow - overvalued
* Some Future EPS Growth marked as green means that the projected earnings growth is even higher; 20% is my maximum

# Lam Research (LRCX): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F765e93e7-9a15-4dfd-8941-4ff521d702ae_1814x935.png)

# ðŸ‘ Positive Points

* Lam Research posted a strong September quarter with revenues and earnings per share exceeding the midpoint of guidance.
* The company achieved its fifth consecutive quarter of revenue growth, indicating strong execution despite a challenging industry environment.
* LRCX is well-positioned to benefit from technology upgrades in NAND, which is expected to drive spending recovery.
* The company is seeing strong momentum in advanced packaging, with SABRE 3D revenue more than doubling this year.
* LRCX is experiencing strong customer demand for productivity enhancements and equipment intelligence services, with increased adoption of its offerings.

# ðŸ‘Ž Negative Points

* Domestic China WFE is expected to decline in the second half of the year, impacting LRCX's revenue from the region.
* Gross margin decreased slightly due to a decline in customer mix and increased incentive compensation.
* Operating expenses increased due to higher program spending and incentive compensation, impacting profitability.
* The NAND segment has experienced a prolonged down cycle, with spending expected to increase only in 2025.
* Lam Research anticipates a headwind in customer mix affecting gross margins due to a lower percentage of revenue from China.

# First Solar (FSLR): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F173d92b6-85d1-4bf3-84c5-e0716430968c_1950x936.png)

# ðŸ‘ Positive Points

* First Solar achieved a record quarterly production of 3.8 gigawatts, demonstrating strong manufacturing capabilities.
* The company inaugurated a new $1.1 billion Alabama facility, adding 3.5 gigawatts of solar manufacturing capacity, with plans for further expansion in Louisiana.
* First Solar has a robust contracted backlog of 73.3 gigawatts, providing long-term revenue visibility.
* The company is launching CuRe production, aiming to enhance its technology offerings and capture additional revenue through contractual adjusters.
* First Solar was recognized by MIT Technology Review and Time Magazine for its leadership in solar technology and innovation.

# ðŸ‘Ž Negative Points

* FSLR faced a $50 million product warranty charge due to manufacturing issues with its Series 7 product.
* The company experienced operational challenges, including hurricanes and logistical disruptions, impacting financial performance.
* There is ongoing pressure from Chinese dumping in the Indian market, leading to depressed ASPs and strategic shifts in production.
* First Solar had to terminate a contract with Plug Power due to project delays, impacting its bookings.
* The company is facing intellectual property challenges within the solar manufacturing sector, particularly related to TOPCon patents.

# Medpace (MEDP): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fdf8268c6-080b-48c0-a735-59cbf582ce11_1928x942.png)

# ðŸ‘ Positive Points

* Revenue for the third quarter of 2024 was $533.3 million, representing a year-over-year increase of 8.3%.
* EBITDA for the third quarter increased by 31.7% compared to the same period in 2023, reaching $118.8 million.
* Net income for the third quarter rose by 36.7% year-over-year, driven by interest income and partially offset by a higher effective tax rate.
* Ending backlog as of September 30, 2024, was approximately $2.9 billion, an increase of 8.8% from the prior year.
* The company expects to convert approximately $1.62 billion of backlog into revenue over the next 12 months, indicating strong future revenue potential.

# ðŸ‘Ž Negative Points

* Backlog cancellations in Q3 were above the usual range, marking three consecutive quarters of elevated cancellations.
* Net new business awards decreased by 12.7% from the prior year, resulting in a net book-to-bill ratio of 1.0 for the quarter.
* The elevated cancellations are expected to depress reported net backlog awards in Q4 and Q1 of 2025.
* RFPs were down modestly on a year-over-year and sequential basis, indicating a potential slowdown in new business opportunities.
* Gross bookings were lower in the quarter due to prior cancellations, impacting the overall business momentum.

# Visa (V): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F379759e2-9697-4734-b89a-f31f8ed60eb8_1799x927.png)

# ðŸ‘ Positive Points

* Visa reported strong financial results for the fourth quarter, with net revenue of $9.6 billion, up 12% year-over-year, and EPS up 16%.
* The company saw significant growth in cross-border volume, excluding intra-Europe, which rose 13%, and processed transactions grew 10% year-over-year.
* Visa continues to expand its consumer payments business, with over 4.6 billion credentials, up 7% year-over-year, and 11.5 billion tokens, with more than 30% of total transactions tokenized.
* The company has made significant strides in new flows, with revenue growing 22% year-over-year in constant dollars, and Visa Direct transactions increasing by 38%.
* Visa has successfully renewed and expanded several key partnerships globally, including agreements with major clients like Grupo Pramerica, SMCC, Alrajhi, and Standard Chartered Bank.

# ðŸ‘Ž Negative Points

* Visa faces regulatory challenges, including a lawsuit by the Department of Justice, which the company believes is meritless.
* The company experienced slower growth in Asia Pacific payments volume, primarily due to macroeconomic conditions, particularly in Mainland China.
* Cross-border travel volume growth was lower than expected, mainly due to challenges in Asia Pacific travel corridors.
* Visa anticipates a significant increase in client incentives in fiscal 2025, which could impact net revenue growth.
* The company expects a step down in adjusted net revenue growth from Q4 2024 to Q1 2025 due to various factors, including increased incentives and the timing of pricing actions.

# Alphabet (GOOGL): Undervalued ðŸŸ¢

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc9aac525-db12-4b3d-8188-e7893e29a638_1837x934.png)

# ðŸ‘ Positive Points

* Alphabet reported a 15% increase in consolidated revenue, with Google Cloud revenue growing by 35% year-over-year.
* The company has made significant advancements in AI, with the Gemini models being integrated across all major products and platforms, reaching over 1 billion users.
* YouTube's combined ad and subscription revenue surpassed $50 billion over the past four quarters, driven by strong growth in YouTube TV, NFL Sunday Ticket, and YouTube Music Premium.
* Alphabet is making substantial investments in clean energy, including a corporate agreement to purchase nuclear energy, supporting its commitment to sustainability.
* The company is seeing strong engagement and increased search usage with the rollout of AI Overviews to over 100 new countries and territories.

# ðŸ‘Ž Negative Points

* Network advertising revenue declined by 2% year-over-year, indicating challenges in this segment.
* The company faces potential legal challenges from the DOJ, which could impact its search agreements with partners like Apple.
* Alphabet is experiencing increased costs, with total cost of revenue up by 10% and operating expenses rising by 5%.
* There is a headwind to year-over-year growth in subscription platforms and devices revenue due to the pull forward of Made by Google launches.
* The company is facing increased competition in the AI space, with a need to continuously innovate to maintain its leadership position.

# Microsoft (MSFT): Fairly Valued ðŸ”µ

[**Updated Valuation (PNG)**](https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd609a767-f662-4d0e-b94e-4f8235f12e6c_1811x941.png)

# ðŸ‘ Positive Points

* Microsoft Cloud revenue surpassed $38.9 billion, marking a 22% increase, driven by strong demand for AI and cloud services.
* AI business is on track to surpass an annual revenue run rate of $10 billion next quarter, making it the fastest-growing business in Microsoft's history.
* Azure and other cloud services revenue grew 33% in constant currency, with healthy consumption trends.
* Microsoft 365 Copilot adoption is accelerating, with nearly 70% of the Fortune 500 using it, and customers continue to adopt it at a faster rate than any other new Microsoft 365 suite.
* LinkedIn revenue increased 10%, with record engagement and growth across all lines of business.

# ðŸ‘Ž Negative Points

* Microsoft Cloud gross margin percentage decreased by 2 points year over year, driven by scaling AI infrastructure.
* Operating expenses increased by 12%, partly due to the Activision acquisition, impacting overall profitability.
* Free cash flow decreased by 7% year over year, reflecting higher capital expenditures to support cloud and AI offerings.
* Supply constraints, particularly in AI infrastructure, are impacting Azure's ability to meet demand, leading to potential growth deceleration.
* The Activision acquisition had a negative $0.05 impact on earnings per share due to purchase accounting adjustments and related costs.",2024-11-01,104,47
1gb78ly_LRCX,LRCX,Keep a close eye on META and LRCX and of course TSLA today,,2024-10-24,2,1
1gb78ly_TSLA,TSLA,Keep a close eye on META and LRCX and of course TSLA today,"I'm riding three names today. META seems to have bottomed this morning. LRCX and TSLA are reacting well to their good earnings. Rising call options, volume and RSI in all three. ",2024-10-24,2,1
1gb78ly_META,META,Keep a close eye on META and LRCX and of course TSLA today,"I'm riding three names today. META seems to have bottomed this morning. LRCX and TSLA are reacting well to their good earnings. Rising call options, volume and RSI in all three. ",2024-10-24,2,1
1gap6de_LRCX,LRCX,"LRCX Beats, Raises, and Rallies","LRCX Beats, Raises, Pumps

Iâ€™ve been a big believer in LRCX since my job as an industrial electrical apprentice has had me installing conduit runs in water manufacturing sites. Lams biggest and baddest tools are beside me day in and day out. When ASML dropped, I had a very strong sense that LRCX was unfairly punished by the market because of my anecdotal experience of witnessing what seems like a constant deject for their tools to be purchased and installed as quickly as possible, and the fact that they have a massive customer support presence in the industry. 

Further research was required. So I did what any sensible person would do and asked chat gpt about the differences between ASML and LRCX, but more specifically about whether the export restrictions that hurt ASML would hurt LRCX equally. The short answer: no. The etch and deposition technologies that LRCX champion are not as restricted as the advanced lithography tech that ASML sells. Finally, China makes up about 1/3rd of their customer base, as opposed to 1/2 in the case of ASML.

Furthermore, the company has sharp leadership, knows how to submit reports on time, has beat earnings now 5x in a row, and has a very high profit margin. Despite this, everyone on here was saying â€œit always drops after earnings, even on a beatâ€. Which freaked me out until I learned that it was literally untrue. They rose on 4/6 of their last 6 earnings (now 5/7).

Today LRCX reported .86 EPS vs estimated .8, and raised guidance for the next quarter. The stock is up about 5.5% AH as I write this with a sitting price of $77 per share. 

I still believe the stock has a lot of room to run. Itâ€™s STILL down about 10% from where it was before the Dutch fucked us all. The only downside I actually see here is that the market seems to be generally down trending for a few days.

TLDR:
I bought a call at $75.00 strike price, it expires 11-29. The stock went up so I am happy, but you should buy it too so it goes higher so I get to be happier. 

",2024-10-23,9,12
1g5c29r_LRCX,LRCX,Will LRCX Prove Doubters Wrong?,"Lam Research is an industry leader in the world of semiconductor manufacturing tools. As an industrial electrician, I work in a facility that I am not legally allowed to talk about here on Reddit. But I see their tools day in and day out. I donâ€™t have any anecdotal experiences that would outweigh the considerations of an objective analyst, who knows the sales and the business on a macro level in greater detail. But it seems to me that there is a bullish comeback story here from what I see is a massive overreaction- and awesome buying opportunity. Here are my thoughts, please weigh in with any useful information or thoughts of your own:

The company has less reliance on Chinese customers than ASML, and export restrictions will do significantly less damage to their bottom line. 

The company is a leader in research and development in the field, keeping them competitive in the highest levels of semiconductor manufacturing, which is where the majority of the dollars in the industry go. 

The company has a very high profit margin (recently read it was around 48%).

The management is lean and hungry. 

They trade at a P/E of about 25, which is 8 dollars per share lower than the industry average, while also having a cash flow per share of 3, which is 2.75 higher than the industry average. 

I guess we will see how things shake out when they report earnings in a week. Personally, Iâ€™m bullish on the company. Iâ€™m opened a $75.00 call expiring 11-29 today, and lost 20% on it. I am expecting it to go back up, or at least consolidate. If nothing else, at least the volatility growth before earnings and the time before exp should keep the premium from getting completely fucked. What do you guys think? Is this a buy or is this cursed? How manic depressive are we feeling today?",2024-10-16,3,25
1fv4opd_LRCX,LRCX,PSA: Lam Research Forward Split 10:1 effective today (Oct 3rd),"Don't be like me and sit down at your desk with a cup of coffee this morning and panic a wee bit after you open your portfolio and see your position is down by 90+%.  

[LCRX](https://i.imgur.com/JXMi80H.png)

From their press release:  

> FREMONT, Calif., May 21, 2024 /PRNewswire/ -- Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors approved a $10 billion share repurchase authorization and a forward split of its outstanding shares of common stock at a ratio of 10:1.
> 
> ""The share repurchase authorization announced today will execute over an indeterminate period of time and is consistent with our plan to return 75% to 100% of free cash flow to stockholders in the form of dividends and share buybacks,"" said Doug Bettinger, Lam's Executive Vice President, and Chief Financial Officer. ""Furthermore, the stock split announced today will enable a larger proportion of Lam's worldwide employee base to participate in the company's employee stock plans.""
> 
> The company is authorized to repurchase up to $10 billion of common stock. The new share repurchase authorization supplements the remaining balances from any prior authorizations. Repurchases may be made through both public market and private transactions and may include the use of derivative contracts and structured share repurchase agreements. This repurchase program has no termination date and may be suspended or discontinued at any time.
> 
> The stock split is expected to be effective after market close on Wednesday, October 2, 2024, for stockholders of record at that time. Lam Research's common stock will begin trading on a post-split basis at the market open on Thursday, October 3, 2024, under the company's existing trading symbol ""LRCX.""
> 
> As a result of the stock split, proportionate adjustments will be made to the number of shares of Lam Research's common stock underlying the company's outstanding equity awards, equity incentive plans, and other existing agreements, as well as exercise or conversion prices, as applicable. The company anticipates filing a Form 8-K with the U.S. Securities and Exchange Commission after the occurrence of the stock split to report an amendment to the company's Restated Certificate of Incorporation effecting the stock split and reflecting a proportionate adjustment to the total number of authorized shares of Lam Research common stock.
> 
> 
> 
>",2024-10-03,13,11
1c7g1ep_LRCX,LRCX,"Out of ASML, LRCX, AMAT, and KLA, which is the best in terms of value?","Iâ€™ve been researching chip stocks and itâ€™s quite fascinating how important each one of these companies are. With the recent run up from AI itâ€™s been hard to fine the value in each company but Iâ€™m curious what everyone elseâ€™s insight is. 

AMAT stands out to me the most at the moment as itâ€™s still a relatively low PE at 23 and itâ€™s dropped 6% the last few days due to ASML and TSMCs earnings.  Most of the other manufactures are still around the 30 range or higher but in the long run Iâ€™m sure theyâ€™re going to be amazing companies. 

I think the only issue is how much these companies rely on selling to China and how thatâ€™s hurting their bottom line quite a bit. Eventually that might change but I think thatâ€™s really unlikely for quite a while. 
",2024-04-18,14,9
15ekx92_LRCX,LRCX,LRCX options,"Bought LRCX $640 Aug 8 Call @ 16.5 on 7/26, several days before earnings. The option price has since risen 400%.

What I would like to learn is why a 10% stock rise after earnings contribed to such a large option increase in this case. 

I've traded other options around earnings and have not seen this type of action. Appreciate any insights to help improve my education!",2023-07-31,4,3
14o9ksj_LRCX,LRCX,Trade failure - Havent recieved money from selling 24 shares of LRCX. Please help.,,2023-07-01,0,8
11k13c8_LRCX,LRCX,"Lam (LRCX) light valuation: solid fundamentals, seems to be trading around intrinsic value",,2023-03-06,0,2
u7zp3p_LRCX,LRCX,Trade Lam Research Earning with Iron Condor,"By [www.odds.trade](https://www.odds.trade)

**Lam Research Corporation** (ticker: LRCX) is scheduled to report Q3-2021 results on Apr 20 after market close. The company expects revenues of **$4.25 billion**, indicating a 10.4% YOY growth. The company anticipates non-GAAP earnings per share of $7.45, indicating a 0.1% fall from the prior-year.

&#x200B;

[Revenue and EPS](https://preview.redd.it/179nw5xhgpu81.png?width=1202&format=png&auto=webp&s=b44f933e975e78a1f22011a06dd573298a4dbcf3)

**Recent Price Action**

Prices of the entire semiconductor sector have been trending down during the last month amid rising concern around supply issues and murky macroeconomics outlook. As the earnings season kicks off, Lam Research price is showing signs of recovery. Short volume and put-call ratio have been declining in the recent weeks, both indicating a positive sentiment of the stock.

[Price Actions](https://preview.redd.it/wp2t81ntgpu81.png?width=528&format=png&auto=webp&s=cf81971b6e693553315d50868f2b974eb84e8ab2)

**Implied Volatility**

Going into the earnings, the IV has been expanding. The current IV rank (as of 4.19 after market close) is 44.11%. This means the implied volatility is roughly at the trailing 12mo average. And since IV percentile is also rather high, a volatility crush strategy seems reasonable.

&#x200B;

[Implied Volatility](https://preview.redd.it/in7hc9n1hpu81.png?width=530&format=png&auto=webp&s=00873b6d1d86b56ea18f11d970d89846d8364c49)

**Implied vs Actual Post-Earning Move**

Lam Research spot price as of 11:40pm on Apr.20 is $484. The at-the-money straddle expired on Apr. 22 is priced at $24. This means that the market expectation of the post-earning price move is between $484 Â± $24. This is known as the implied move. During the last 4 earnings, the actual moves tend to move around the lower end of the expected moves, but by-and-large closed within the market expectations.

&#x200B;

[Historic Implied vs Actual Post-Earning Move](https://preview.redd.it/p2omvqk5hpu81.png?width=1265&format=png&auto=webp&s=a3d82ddd256f59a3d94ddf77ef3ab1dda6d3e131)

**Proposed Trade**

My proposed trade is a Short Iron Condor strategy expired on Apr. 22.

**Enter on** Apr. 20 before market close, find out the latest stock price of LCRX, and the 04â€“22â€“22 at-the-money straddle cost to build the trade. 

For example, if the stock price then is 484 and straddle cost is 24, the Iron Condor can be built in the following way:

Strike prices for the short legs are based on the market expected moves:

Step 1: Sell $460 Put ($484-$24)

Step 2: Sell $510 Call ($484+ $24)

Strike prices for the long legs are based on the risk tolerance of the traders:

Step 3: Buy $455 Put ($460-$5)

Step 4: Buy $515 Call ($510 + $5)

Expiration date for all 4 contracts is **Apr. 22, 2022.** 

I choose $5 width spreads on both the call and put sides. The total credit (max profit)collected from this trade is $170, and the max loss $330 ($5\*100 -$170). The probability of profit of this trade is around 80%, which is considered as a high probability trade.

**Exit if** the trade is profited on Apr. 21, **close all 4 positions** before market close to reduce the risk exposure on Apr. 22.

**Caveats**\- It is **NOT** recommended to hold the strategy through expiration even if the price looks safe. Gamma risk can be dangerous.- Exit after 50% profit is also a popular take-profit strategy.

**Disclaimer**: this is just my personal insight which is not construed as investment advice.

**Please UPVOTE if you like this post!!! Thank you!!!**

&#x200B;",2022-04-20,5,3
tghq8k_LRCX,LRCX,Managed to sell some LRCX puts at juuuust the right time.,,2022-03-17,23,5
s2uon8_LRCX,LRCX,LRCX 660 put expires 2/25,I yoloed 8k in this and already lost 3k should I just take loss and move on?,2022-01-13,1,10
r6idlb_LRCX,LRCX,Baby Gains - LRCX,,2021-12-01,10,3
r52b3w_LRCX,LRCX,LRCX - Baby Gains,,2021-11-29,25,3
qsg45t_LRCX,LRCX,Long LRCX - Jan 2024 Calls $560 Strike Price - YOLO,,2021-11-12,14,16
qsmq1p_LRCX,LRCX,Loaded some calls $LRCX,,2021-11-12,5,9
ph7zba_LRCX,LRCX,"Looking for ""Chip Shortage"" buys? Here are the companies that make the things that make the chips! ASML , AMAT , LRCX , KLAC","In a world full of bouncy meme ticker charts, these stonks have charts that look so warm and green and inviting with a nice slow steady staircase to the moon. ðŸŒ™   I don't give financial advise ,  but IMHO the chip shortage is not over, and has not seen nearly the news coverage it perhaps should be getting.  As it quietly gets worse, more alternatives will begin to stand up and this list are the folks they need to call to get the ball rolling.  I would think it might make sense to also buy in to the raw material companies involved, though I do not have that list yet.  What do you think?  This is a discussion thread.",2021-09-03,44,40
ph7zba_KLAC,KLAC,"Looking for ""Chip Shortage"" buys? Here are the companies that make the things that make the chips! ASML , AMAT , LRCX , KLAC",,2021-09-03,45,40
p2v8y4_LRCX,LRCX,"Thirteen stocks possibly worth attention, a consensus strategy: FAF, FB, FSS, GLPI, HWKN, ICLR, IEX, JNJ, LRCX, MDLZ, OTEX, QCOM, QRVO",,2021-08-12,192,82
p2v8y4_QCOM,QCOM,"Thirteen stocks possibly worth attention, a consensus strategy: FAF, FB, FSS, GLPI, HWKN, ICLR, IEX, JNJ, LRCX, MDLZ, OTEX, QCOM, QRVO"," 

Here is a couple of stocks that might be worth your attention this week. This is part 2 of 2.

This is not a sponsored content. I'm just sharing my thoughts with you, hoping you're going to enjoy it.

This  short list was compiled with help of various sources of data, including  Buy recommendations from several renowned stock data providers and  analytical services. This is why Iâ€™m calling the approach a **consensus strategy.**  The stocks Iâ€™m going to present you below are generally believed to  outperform the stock market in the coming months, they have a consensus  recommendation of Buy, their fundamentals are scored considerably better  than most stocks and their average target price by stock analysts is  above current market valuation.

In order to consider buying the stockâ€™s shares, the following criteria need to be satisfied:

* **TheStreet score**: A+, A or A-
* **Zacks Rank**: 1 (Strong Buy), 2 (Buy) or 3      (Hold)
* **Weiss Ratings recommendation**: A or B
* **Yahoo Finance recommendation**: at least mixed Buy/Hold
* **MarketBeat recommendation**: at least mixed Buy/Hold
* **Yahoo Finance target price**: min. 5% higher than current      price
* **MarketBeat target price**: min. 5% higher than current      price
* **Piotroski F-Score**: min. 4
* **Moodyâ€™s Daily Credit Risk**: 1 to 6
* **InvestorsObserver Overall Score**: min. 50

**Note**: Descriptions of those criteria are provided at the end of this post.

If  you decide to buy any of the below stocks, you might want to consider  the following selling conditions (at least one of them should be  satisfied):

* price is higher or close to      target
* profit is in range 20% â€“ 30%
* loss is higher than 50%
* TheStreet recommendation is      changed to Sell
* Weiss Ratings recommendation is      changed to Sell
* Yahoo Finance recommendation is      changed to Sell

**Letâ€™s now take a look at the stocks Iâ€™ve identified with this strategy today.**

&#x200B;

**FIRST AMERICAN FINANCIAL CP (FAF)**

**Sector**: Finance  
**Industry**: Specialty Insurance  
**Description**:  First American Financial Corp. operates as an insurance company. It  provides title insurance and settlement services to the real estate and  mortgage industries. The company operates its business through the  following segments: Title Insurance \&amp; Services and Specialty  Insurance. First American Financial was founded in January, 2008 and is  headquartered in Santa Ana, CA.  
**Dividend**:  First American Financial pays an annual dividend of $1.84 per share,  with a dividend yield of 2.69%. FAFâ€™s most recent quarterly dividend  payment was made to shareholders of record on Tuesday, June 15. The  company has grown its dividend for the last 1 consecutive years and is  increasing its dividend by an average of 7.32% each year. First American  Financial pays out 33.76% of its earnings out as a dividend.  
**Current valuation**: $64.85

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy/Hold  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $74.8  
MarketBeat target price: $73.00  
Piotroski F-Score: 8  
Moodyâ€™s Daily Credit Risk: 4  
InvestorsObserver Overall Score: 52  
Yahoo Finance 1 year change: 15.34%

&#x200B;

**FACEBOOK INC (FB)**

**Sector**: Technology Services  
**Industry**: Internet Software/Services  
**Description**:  Facebook, Inc. is focused on building products that enable people to  connect and share through mobile devices, personal computers and other  surfaces. The Companyâ€™s products include Facebook, Instagram, Messenger,  WhatsApp and Oculus. Facebook enables people to connect, share,  discover and communicate with each other on mobile devices and personal  computers. Instagram enables people to take photos or videos, customize  them with filter effects, and share them with friends and followers in a  photo feed or send them directly to friends. Messenger allows  communicating with people and businesses alike across a range of  platforms and devices. WhatsApp Messenger is a messaging application  that is used by people around the world and is available on a range of  mobile platforms. Its Oculus virtual reality technology and content  platform offers products that allow people to enter an interactive  environment to play games, consume content and connect with others.  
**Dividend**: NA  
**Current valuation**: $360.33

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $386.47  
MarketBeat target price: $402.76  
Piotroski F-Score: 7  
Moodyâ€™s Daily Credit Risk: 1  
InvestorsObserver Overall Score: 79  
Yahoo Finance 1 year change: 7.33%

&#x200B;

**FEDERAL SIGNAL CORP (FSS)**

**Sector**: Producer Manufacturing  
**Industry**: Trucks/Construction/Farm Machinery  
**Description**:  Federal Signal Corp. engages in the designed manufacture of products  and integrated solutions for municipal, governmental, industrial, and  commercial customers. It operates through the Environmental Solutions  Group and Safety and Security Systems Group segments. The company was  founded in 1901 and is headquartered in Oak Brook, IL.  
**Dividend**:  Federal Signal pays an annual dividend of $0.36 per share, with a  dividend yield of 0.90%. FSSâ€™s next quarterly dividend payment will be  made to shareholders of record on Wednesday, September 1. The company  has grown its dividend for the last 1 consecutive years and is  increasing its dividend by an average of 4.55% each year. Federal Signal  pays out 21.56% of its earnings out as a dividend.  
**Current valuation**: $39.81

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $45.33  
MarketBeat target price: $44.00  
Piotroski F-Score: 4  
Moodyâ€™s Daily Credit Risk: 6  
InvestorsObserver Overall Score: 56  
Yahoo Finance 1 year change: 13.87%

&#x200B;

**GAMING & LEISURE PPTYS (GLPI)**

**Sector**: Finance  
**Industry**: Real Estate Investment Trusts  
**Description**:  Gaming & Leisure Properties, Inc. is engaged in acquiring,  financing, and owning real estate property to be leased to gaming  operators in triple net lease arrangements. It operates through the GLP  Capital and TRS Properties segments. The GLP Capital segment consists of  the leased real property and represents the majority of business. The  TRS Properties segment includes Hollywood Casino Perryville and  Hollywood Casino Baton Rouge. The company was founded on February 13,  2013 and is headquartered in Wyomissing, PA.  
**Dividend**:  Gaming and Leisure Properties pays an annual dividend of $2.68 per  share, with a dividend yield of 5.56%. GLPIâ€™s most recent quarterly  dividend payment was made to shareholders of record on Friday, June 25.  Gaming and Leisure Properties pays out 77.68% of its earnings out as a  dividend.  
**Current valuation**: $47.86

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Buy  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy/Hold  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $51.08  
MarketBeat target price: $50.25  
Piotroski F-Score: 7  
Moodyâ€™s Daily Credit Risk: 4  
InvestorsObserver Overall Score: 60  
Yahoo Finance 1 year change: 6.73%

&#x200B;

**HAWKINS INC (HWKN)**

**Sector**: Distribution Services  
**Industry**: Wholesale Distributors  
**Description**:  Hawkins, Inc. engaged in the distribution, blending, and manufacture of  chemicals and specialty ingredients for a wide variety of industries.  It operates through the following segments: Industrial, Water Treatment,  and Health and Nutrition. The company was founded by Howard Hawkins in  1938 and is headquartered in Roseville, MN.  
**Dividend**:  Hawkins pays an annual dividend of $0.49 per share, with a dividend  yield of 1.33%. HWKNâ€™s next quarterly dividend payment will be made to  shareholders of record on Friday, August 27. The company has grown its  dividend for the last 1 consecutive years and is increasing its dividend  by an average of 2.64% each year. Hawkins pays out 25.39% of its  earnings out as a dividend.  
**Current valuation**: $36.80

**Valuation of entry parameters:**

TheStreet score: A  
Zacks Rank: Buy  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $44.0  
MarketBeat target price: $44.00  
Piotroski F-Score: 8  
Moodyâ€™s Daily Credit Risk: 6  
InvestorsObserver Overall Score: 51  
Yahoo Finance 1 year change: 137.84%

&#x200B;

**ICON PLC (ICLR)**

**Sector**: Health Technology  
**Industry**: Pharmaceuticals: Other  
**Description**:  ICON plc operates as a clinical research organization, which engages in  the provision of outsourced development services to the pharmaceutical,  biotechnology, and medical device industries. It specializes in the  strategic development, management and analysis of programs that support  clinical development. The company was founded by John Climax and Ronan  Lambe in June 1990 and is headquartered in Dublin, Ireland.  
**Dividend**: NA  
**Current valuation**: $235.92

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Buy  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $251.42  
MarketBeat target price: $251.00  
Piotroski F-Score: 6  
Moodyâ€™s Daily Credit Risk: 2  
InvestorsObserver Overall Score: 80  
Yahoo Finance 1 year change: 6.57%

&#x200B;

**IDEX CORP (IEX)**

**Sector**: Finance  
**Industry**: Investment Banks/Brokers  
**Description**:  Indian Energy Exchange Ltd. Engages in power exchange business and  provides an automated platform for trading of electricity and related  products. It enables trading and price discovery of electricity and  related products with risk management for participants of the  electricity market. The firmâ€™s products include day-ahead-market (DAM)  electricity contracts, term-ahead-market (TAM) electricity contract,  Renewable Energy Certificates (REC) and Energy Saving Certificates. The  company was founded on March 26, 2007 and is headquartered in Noida,  India.  
**Dividend**:  IDEX pays an annual dividend of $2.16 per share, with a dividend yield  of 0.95%. IEXâ€™s most recent quarterly dividend payment was made to  shareholders of record on Friday, July 30. The company has grown its  dividend for the last 1 consecutive years and is increasing its dividend  by an average of 11.31% each year. IDEX pays out 41.62% of its earnings  out as a dividend.  
**Current valuation**: $227.11

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Buy  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy/Hold  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $242.25  
MarketBeat target price: $239.50  
Piotroski F-Score: 5  
Moodyâ€™s Daily Credit Risk: 2  
InvestorsObserver Overall Score: 69  
Yahoo Finance 1 year change: 6.61%

&#x200B;

**JOHNSON & JOHNSON (JNJ)**

**Sector**: Health Technology  
**Industry**: Pharmaceuticals: Major  
**Description**:  Johnson \&amp; Johnson is a holding company, which is engaged in the  research and development, manufacture and sale of a range of products  in the healthcare field. It operates through three segments: Consumer,  Pharmaceutical and Medical Devices. Its primary focus is products  related to human health and well-being. Its research facilities are  located in the United States, Belgium, Brazil, Canada, China, France,  Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland  and the United Kingdom.  
**Dividend**:  Johnson & Johnson pays an annual dividend of $4.24 per share, with a  dividend yield of 2.44%. JNJâ€™s next quarterly dividend payment will be  made to shareholders of record on Tuesday, September 7. The company has  grown its dividend for the last 59 consecutive years and is increasing  its dividend by an average of 6.23% each year. Johnson & Johnson  pays out 52.80% of its earnings out as a dividend.  
**Current valuation**: $173.82

**Valuation of entry parameters:**

TheStreet score: A  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $187.39  
MarketBeat target price: $190.38  
Piotroski F-Score: 7  
Moodyâ€™s Daily Credit Risk: 1  
InvestorsObserver Overall Score: 62  
Yahoo Finance 1 year change: 7.81%

&#x200B;

**LAM RESEARCH CORP (LRCX)**

**Sector**: Electronic Technology  
**Industry**: Electronic Production Equipment  
**Description**:  Lam Research Corp. engages in manufacturing and servicing of wafer  processing semiconductor manufacturing equipment. It operates through  the following geographical segments: the United States, China, Europe,  Japan, Korea, Southeast Asia, and Taiwan. It offers thin film  deposition, plasma etch, photoresist strip, and wafer cleaning. The  company was founded by David Lam on January 21, 1980 and is  headquartered in Fremont, CA.  
**Dividend**:  Lam Research pays an annual dividend of $5.20 per share, with a  dividend yield of 0.86%. LRCXâ€™s most recent quarterly dividend payment  was made to shareholders of record on Wednesday, July 7. The company has  grown its dividend for the last 3 consecutive years and is increasing  its dividend by an average of 38.36% each year. Lam Research pays out  19.09% of its earnings out as a dividend.  
**Current valuation**: $599.8

**Valuation of entry parameters:**

TheStreet score: A  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $728.43  
MarketBeat target price: $713.94  
Piotroski F-Score: 7  
Moodyâ€™s Daily Credit Risk: 6  
InvestorsObserver Overall Score: 65  
Yahoo Finance 1 year change: 21.45%

&#x200B;

**MONDELEZ INTERNATIONAL INC (MDLZ)**

**Sector**: Consumer Non-Durables  
**Industry**: Food: Major Diversified  
**Description**:  Mondelez International, Inc. engages in the manufacture and marketing  of snack food and beverage products. It operates through the following  geographical segments: Latin America; Asia, Middle East, and Africa;  Europe; and North America. Its products include beverages, biscuits,  chocolate, gum & candy, cheese \&amp; grocery and meals. Its  brands include but not limited to Nabisco, Oreo, and LU biscuits;  Cadbury, Cadbury Dairy Milk, and Milka chocolates; and Trident gum. The  company was founded by James Lewis Kraft in 1903 is headquartered in  Chicago, IL.  
**Dividend**:  Mondelez International pays an annual dividend of $1.26 per share, with  a dividend yield of 2.01%. MDLZâ€™s next quarterly dividend payment will  be made to shareholders of record on Thursday, October 14. The company  has grown its dividend for the last 8 consecutive years and is  increasing its dividend by an average of 13.53% each year. Mondelez  International pays out 48.65% of its earnings out as a dividend.  
**Current valuation**: $62.59

**Valuation of entry parameters:**

TheStreet score: A  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $69.17  
MarketBeat target price: $67.90  
Piotroski F-Score: 7  
Moodyâ€™s Daily Credit Risk: 1  
InvestorsObserver Overall Score: 68  
Yahoo Finance 1 year change: 10.51%

&#x200B;

**OPEN TEXT CORP (OTEX)**

**Sector**: Technology Services  
**Industry**: Packaged Software  
**Description**:  Open Text Corp. engages in the design, development, marketing and sales  of enterprise information management software and solutions. It  includes customer experience management (CEM), digital process  automation, business network, and enterprise content management,  discovery, security, and artificial intelligence (AI) and analytics  solutions. It also offers consulting, managed, and learning services.  The company was founded on June 26, 1991 and is headquartered in  Waterloo, Canada.  
**Dividend**:  Open Text pays an annual dividend of $0.38 per share, with a dividend  yield of 0.72%. OTEXâ€™s next quarterly dividend payment will be made to  shareholders of record on Friday, September 24. The company has grown  its dividend for the last 7 consecutive years and is increasing its  dividend by an average of 12.35% each year. Open Text pays out 13.57% of  its earnings out as a dividend.  
**Current valuation**: $52.62

**Valuation of entry parameters:**

TheStreet score: A  
Zacks Rank: Hold  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $56.95  
MarketBeat target price: $60.00  
Piotroski F-Score: 6  
Moodyâ€™s Daily Credit Risk: 6  
InvestorsObserver Overall Score: 57  
Yahoo Finance 1 year change: 8.23%

&#x200B;

**QUALCOMM INC (QCOM)**

**Sector**: Electronic Technology  
**Industry**: Telecommunications Equipment  
**Description**:  QUALCOMM, Inc. engages in the development, design, and provision of  digital telecommunications products and services. It operates through  the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm  Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI).  The company was founded by Franklin P. Antonio, Adelia A. Coffman,  Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and  Harvey P. White in July 1985 and is headquartered in San Diego, CA.  
**Dividend**:  QUALCOMM pays an annual dividend of $2.72 per share, with a dividend  yield of 1.87%. QCOMâ€™s next quarterly dividend payment will be made to  shareholders of record on Thursday, September 23. The company has grown  its dividend for the last 1 consecutive years and is increasing its  dividend by an average of 4.69% each year. QUALCOMM pays out 81.44% of  its earnings out as a dividend.  
**Current valuation**: $145.03

**Valuation of entry parameters:**

TheStreet score: A  
Zacks Rank: Buy  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $171.44  
MarketBeat target price: $167.54  
Piotroski F-Score: 7  
Moodyâ€™s Daily Credit Risk: 6  
InvestorsObserver Overall Score: 70  
Yahoo Finance 1 year change: 18.21%

&#x200B;

**QORVO INC (QRVO)**

**Sector**: Electronic Technology  
**Industry**: Semiconductors  
**Description**:  Qorvo, Inc. engages in the provision of development and  commercialization of technologies and products for wireless and wired  connectivity. It operates through the following reportable segments:  Mobile Products and Infrastructure & Defense Products. The firmâ€™s  products include amplifiers, control products, discrete transistors,  filters \&amp; duplexers, frequency converters \&amp; sources,  integrated products, optical components, passives, power management  products, switches, and wireless connectivity products. The company was  founded on December 13, 2013 and is headquartered in Greensboro, NC.  
**Dividend**: NA  
**Current valuation**: $188.32

**Valuation of entry parameters:**

TheStreet score: A-  
Zacks Rank: Buy  
Weiss Ratings recommendation: Buy  
Yahoo Finance recommendation: Buy  
MarketBeat recommendation: Buy  
Yahoo Finance target price: $208.26  
MarketBeat target price: $205.14  
Piotroski F-Score: 8  
Moodyâ€™s Daily Credit Risk: 6  
InvestorsObserver Overall Score: 74  
Yahoo Finance 1 year change: 10.59%

&#x200B;

**Now, a few words on the criteria Iâ€™m using and sources of data.**

**1. TheStreet score**

The first filtering step is to get stocks with Buy recommendation at TheStreet stock screener. Iâ€™m only keeping stocks with A+, A or A- rating (top ones), although A-, B+, B and B- are Buys as well.

From thestreet.com:

***A (Excellent)*** *â€“  The stock has an excellent track record for maximizing performance  while minimizing risk, thus delivering the best possible combination of  total return on investment and reduced volatility. It has made the most  of the recent economic environment to maximize risk-adjusted returns  compared to other stocks. While past performance is just an indication â€”  not a guarantee â€” we believe this fund is among the most likely to  deliver superior performance relative to risk in the future as well.*

And about the methodology:

*TheStreet  Ratingsâ€™ stock model projects a stockâ€™s total return potential over a  12-month period including both price appreciation and* ***dividends***\*.  Our Buy, Hold or Sell ratings designate how we expect these stocks to  perform against a general benchmark of the equities market and interest  rates. While our model is quantitative, it utilizes both\* ***subjective*** *and* ***objective*** *elements.  For instance, subjective elements include expected equities market  returns, future interest rates, implied industry outlook and forecasted  company earnings. Objective elements include volatility of past  operating revenues, financial strength, and company cash flows.*

**2. Zacks Rank**

It  is required that the Zacks Rank is Hold, Buy or Strong Buy (so weâ€™re  avoiding stocks with Sell and Strong Sell recommendations). The Zacks  Rating utilizes a completely different system, based on company  earnings-related data, in particular earnings estimate revisions and  earnings surprises, to predict profitability of holding the companyâ€™s  shares.

**3. Weiss Ratings recommendation**

Weâ€™re only keeping stocks with Buy (B) or Strong Buy (A) recommendation.

Wjat are these scores? This is what I found at their website:

*â€œAâ€ Rating:* ***Excellent.*** *The  companyâ€™s stock has an excellent track record for providing strong  performance with lower-than-average risk, and it is trading at a price  that represents good value relative to the companyâ€™s earnings prospects.  While past performance is no guarantee of future results, our opinion  is that this stock is among the most likely to deliver superior  performance relative to risk in the future. Of course, even the best  stocks can decline in a down market. But our â€œAâ€ rating can generally be  considered the equivalent of a â€œ****Strong Buy****â€œ.*

*â€œBâ€ rating:* ***Good.*** *The  companyâ€™s stock has a good track record for delivering a balance of  performance and risk. While the risk-adjusted performance of any stock  is subject to change, our opinion is that this stock is a good value,  with good prospects for outperforming the market. Although even good  investments can decline in a down market, our â€œBâ€ rating is considered  the equivalent of a â€œ****Buy****â€œ.*

**4.  Yahoo Finance  recommendation and target price**

It is required that the Yahoo Finance  stock recommendation is at least mixed Buy/Hold from experts.  Additionally, the predicted target price (average, from experts) should  be at least 5% higher than the current one.

**5. MarketBeat recommendation and taget price**

Similar to Yahoo Finance, it is required that the MarketBeat stock recommendation is at least mixed Buy/Hold. Additionally, the  predicted target price (average, from experts) should be at least 5%  higher than the current valuation.

**6. Piotroski F-Score**

The  Piotroski score is a number between 0-9 that reflects nine criteria  used to determine the strength of a companyâ€™s financial situation,  including profitability, leverage or operating efficiency. Zero is the  worst value and nine is the best. As we can read in Piotroski's paper from 2000:

*In addition, an investment strategy that buys expected winners and shorts expected losers generates a* ***23% annual return*** *between 1976 and 1996, and the strategy appears to be robust across time and to controls for alternative investment strategies.*

It is required that the score is 4 or higher. The values were retrieved from gurufocus website.

**7. Moodyâ€™s Daily Credit Risk**

Moodyâ€™s  Daily Credit Risk Score is a 1-10 score, which provides a  forward-looking, one-year measure of credit risk. It is updated daily  and takes into account day-to-day market movements compared to a  companyâ€™s liabilities.

The value is retrieved from Business Insider's website and is expected to be in the range of 1-6.

**8. InvestorsObserver Overall Score**

The rank has a value in between 0 and 100. It takes into account both **technical** analysis and **fundamental**  stock data. An Overall Rank of N means that a given company is rated  above N% of stocks, therefore the higher the number, the better. My  requirement is that the company has InvestorsObserver Overall score of  at least 50. From their website:

*The  Overall Score combines our two technical scores (Short Term and Long  Term) with our Fundamental Score into one metric. This makes our overall  score a great place to start when evaluating stocks, regardless of your  investing style.*

*A  low score doesnâ€™t necessarily mean a stock is likely to go down, just  that our system doesnâ€™t think thereâ€™s much of a bullish case for it.*

Please note that the company profile data (short description) was taken from  tradingview website (sometimes I shortened it) and dividend data was retrieved from MarketBeat.

I  hope you enjoyed the reading. What do you think about this stock  selection and the strategy? Feel free to leave a comment below.

*Michael*

Disclosures:

* What you see here is my      personal opinion, my own investments and should not be treated as      investing advice
* Iâ€™m an amateur investor",2021-08-12,194,82
orl9nn_LRCX,LRCX,Why does Google finance show earnings beats and misses before the quarters? Example LRCX?,,2021-07-25,6,5
nxq9s8_LRCX,LRCX,LRCX is the semiconductor play for 2021-2022,"**tl;dr:** LRCX will benefit tremendously from the US push to produce semiconductors. Buy shares and LEAPS. 

**Position:** 103x LRCX shares with DRIP (dividend reinvestment) and 1x 1/2023 $500c.

**The DD:** 

* The push within the US to produce semiconductors (microchips) inside American borders has encouraged companies like INTC, TSMC, and Samsung to commit to building multi-million dollar fab plants (semiconductor factories). 
* The semiconductor shortage in general indicates there is demand for more semis.
* The 5G and IoT rollouts means semiconductor demand will remain high and manufactories are likely to expand further.

LRCX is well-positioned to make money off this. LRCX builds the machines and does the research that these other companies need to make microchips. Without LRCX, there are no manufactories. And after the fab plants are built, the machines need maintenance. LRCX provides this maintenance at 30%+ margins.

**Fundamentals:**

&#x200B;

[Beats Earnings](https://preview.redd.it/t67m821yap471.png?width=407&format=png&auto=webp&s=37ee8d9b94a3a0f5bfcb12d1fb6317bb5747c0fa)

LRCX has beat earnings 4/4 of the last quarters. It has the growth potential to continue beating earnings.

At a 27 P/E ratio, its valuation is average in its industry and has room to climb.

**Technicals:** 

&#x200B;

[Up and to the right](https://preview.redd.it/xwr8epatap471.png?width=559&format=png&auto=webp&s=cc38dae385b63dcd764d4509061508a2cf9206ed)

LRCX goes up and to the right. It has the fundamental backing to continue. Demand for shares increases as the stock gets down to $600.

&#x200B;

[RSI, MACD, Moving Averages](https://preview.redd.it/85xb9jk9bp471.png?width=898&format=png&auto=webp&s=e471b714290c3175f09ac20a21b391f4e2ea7b88)

MACD looks like shit, but RSI is positive and LRCX travels along its 50-DMA pretty well. Look to start DCAing into shares around this level and buy more shares or LEAPS as we approach $600.

**Competition:**

AMAT competes with LRCX in most industry segments. However LRCX stands out as the best wafer developer. If you cannot afford LRCX at $600, AMAT is $136. AMAT is also more diversified and is a good alternative choice.

There are some others including a Dutch company, but AMAT and LRCX are the main competitors in this industry, and they both have a wide moat.",2021-06-11,18,13
ngln38_LRCX,LRCX,[May 19] Bullish symbol crossing SMA100 in 15min Chart [SOXL/VST/NOVA/AMAT/LRCX],"&#x200B;

||Name|Industrial|Price/Change %|Relative volume|
|:-|:-|:-|:-|:-|
|SOXL|Direxion Daily Semi Bull 3x|ETF , Semiconductor|$ 32.05 / +5.81%|125%|
|VST|Vistra Corp|Utility, Power, Renewable Energy|$ 16.53 / +2.35 %|85%|
|NOVA|Sunnova Energy int.|Utility, Power, Renewable Energy|$ 27.87 / + 5.05%|151%|
|AMAT|Applied Material Inc.|Semiconductor, equipment|$ 124.8 / +2.45%|92%|
|LRCX|Lam Research|Semiconductor, equipment|$ 602.2 / + 2.97%|91%|

&#x200B;

https://preview.redd.it/euxq552256071.png?width=1406&format=png&auto=webp&s=f1e508bbeb00d1976a41b37f1691f05dbfd0bf43

&#x200B;

https://preview.redd.it/nvb2zhm356071.png?width=1202&format=png&auto=webp&s=169b84d00113adb8300f953f5fa6a241884c9a4d

Source: stock pick from W-lab, charting using TradingView, map using finviz:",2021-05-20,1,0
mi3gog_LRCX,LRCX,After a long time . 10X and 8X on the same day . Thank you AMD and LRCX,,2021-04-01,308,62
m1orcz_KLAC,KLAC,"Does TSMC rely on LRCX, AMAT KLAC etc?",,2021-03-10,11,34
m1orcz_LRCX,LRCX,"Does TSMC rely on LRCX, AMAT KLAC etc?","I own some LRCX and also some TSM.  Lately I've been wondering how safe it is investing in TSM because of China trade wars, etc.

Is it safe investing in TSM?  Could US investors somehow lose their money if something went down?

I was also curious who buys products from companies such as Lam Research, Applied Materials, and maybe KLAC.

Does TSMC use products from any of those companies?

Why doesn't the US manufacture semiconductors is another curiosity I've had recently?

Thanks.",2021-03-10,11,34
lvx2qs_AVGO,AVGO,LRCX NVDA ASML AVGO and TSM,,2021-03-02,9,46
lvx2qs_LRCX,LRCX,LRCX NVDA ASML AVGO and TSM,"I'm looking to get rid of at least 1 of these stocks in the semiconductor space.  Would you keep all 5?

Which one would make the most sense to ditch?  

I mean do any of them overlap or perform similar?

I've checked various 10, 5, 20 years etc in portfolio visualizer and they've all performed very well imo.

I'm looking to trade out one of them for UNP, which may sound crazy, but in trying to add some industrial and I already have HON.

I also have TTWO but thought I should keep it for the gaming sector.  It's also done very well, but I just acquired it a month ago.  

Thanks",2021-03-02,9,46
kco79a_KLAC,KLAC,Lam Research - A speculative analysis (LRCX),"# Introduction:

Welcome back everyone. I am back again for another speculation analysis. 

Sector: Technology (Semiconductor Equipment and Materials)

## Company Strengths & Risks:
Lam Research is a wafer fabrication supplier for the semiconductor industry. Now let me break down that sentence for the non-techieâ€™s of the subreddit. Wafers are thin components for semiconductors. A semiconductor is a material that can mimic and flip between a conductor (let electricity pass) and an insulator (not allow electricity). They are made small and thin so as to minimize time between instructions. 

Strengths:
- Required for circuitry and technological advancements
- 5G on the rise- they will need wafers in mass production
- Very high growth ceiling
- WFH and corona was a boon to the business (mostly positive, precautions still in place)

Risks:
- Lots of competitors. Not certain if all are on the stock exchange but Applied Materials (AMAT), KLA (KLAC), Teradyne (TER), Entegris (ENTG), MKS Instruments (MKSI), and Brooks Automation (BRKS) are some decent ones to compare
-  This is a growth stock more than a dividend growth stock. They do grow the dividend but this is being evaluated more based on growth than dividend (to be ranted about later)
- Depth and complexity of chips will always increase. This is the flipside to growth. It has the balance sheet, and I am not worried. But as technology evolves, semiconductors need to evolve too. Like stronger NAND flash (usbs and SD cards) for a short example.
- China ban/embargo. Demand will remain but if the US is banned from exporting to China, it will need to be rerouted elsewhere. Immediate response is that they are in the application process as of Q3 earnings call, of getting the license to ship to China. As a positive, this shows their dedication to stick to their ethics and corporate compliance policies.


## Financial History and numbers

LRCX: 
Numbers from [Seeking Alpha](https://seekingalpha.com/symbol/LRCX/dividends/dividend-growth) and [Yahoo Finance](https://finance.yahoo.com/quote/LRCX/balance-sheet?p=LRCX) as of Dec 12 2020


Stock                        |  LRCX
-----------------------------|-------- 
P/E Ratio                    | 27.9 (forward P/E 19.64)
Stock price                  | $491.70 
Current Annual Payout/Share | $5.20 
Yield                       | 1.06%
10 Yr Div Growth Rate       | -%
3 Yr Div Growth Rate        | 49.37%  
1 Yr Div Growth Rate        | 8.89% 
Years Of Growth             | -
Current Payout Ratio        | 23.24% 
Free Cash Flow / Share      |  14.05
Revenue                     | 3.3B
Debt / Equity Ratio         |  1.12

Lam Research has been paying a dividend since 2014 and has increased the dividend quite consistently. The payout ratio of 23% tells me that they have room to grow for a while. The downside is that the rate of increasing dividends is inconsistent but it does grow. But from a growth perspective, Lam is up 533% in 5 years, up 79% in 1 year. I donâ€™t think this growth is anywhere close to done. I am uncertain as to why seeking alpha does not list years of growth but I will leave it empty due to that.

Potential payout based on 1 year growth rate (estimate. Actual mileage may vary)


Year | LRCX
------|------------
2021 |  5.66  
2022 |  6.16
2023 |  6.71 
2024 |  7.31  

## Growth Potential Rant
One of my main realizations early on is that technology is ever evolving. In this day and age, it seems to be going exponentially rather than linearly. Circuitry is at the baseline of technology. 
Da Vinci Surgical Robot: A couple of months ago, you may have seen a video of the Da Vinci Surgical Systems robot allowing minimally invasive surgery. While this robot was not made by LRCX, it just shows the evolution of technology and how circuity is coming to other sectors. 
The rise of 5G: Weâ€™ve heard it all over. 5G is coming. Guess what, semiconductors will be involved. I think this may be the safer play rather than speculating on the communication sector, or the first company to release 5G. Instead of betting on those, why not speculate on safe suppliers of 5G components? Well what happens after 5G becomes mainstream? I don't think this is even close to the pinnacle. Years ago, LTE and 4G were phenomenal. Now 5G is the new buzz. Technology evolves. What will come in the future to make 5G obsolete? Iâ€™m near certain semiconductors will be involved.
Other electronics: As technology evolves and semiconductors are further optimized, I expect other electronics to adapt too. Motherboards, CPUs, GPUs, tablets, remote controlled toys, and so much more all benefit from semiconductor optimization. Faster command execution, cheaper products, smaller products. There is just so much room.
We are approaching the point where technology can do things that may not be needed. [Robo Dog](https://www.bostondynamics.com/spot). Point in case, we are optimizing robotic pets.
I really don't see the upper bound of semiconductor use. Technology will keep evolving so semiconductors will evolve with them.

## Final Thoughts:

I don't want to oversell my conviction but I think this sub-industry may be one of the Teslas of dividends. This stock is barely talked about, unlike disruptive stocks like SQ. This company has room to sprint, keep paying dividends, it's practically all we want out of a growth stock but pays a growing dividend too. When the biggest downside is the many competitors, and yet they are still rocketing, I think they are positioned well for the future. 

I hope someone out there found this post interesting. Please supplement this with your own research.

Thank you for reading, please give me feedback so that I can increase my standards for future analysis posts.",2020-12-14,42,15
kco79a_LRCX,LRCX,Lam Research - A speculative analysis (LRCX),,2020-12-14,45,15
jfknjv_LRCX,LRCX,LRCX Up after hours (Semi equipment),,2020-10-21,2,0
jfkn1e_LRCX,LRCX,LRCX Up after hours (Semis)," Highlights for the September 2020 quarter were as follows:

* Revenue of $3.18 billion.
* U.S. GAAP gross margin of 47.4%, U.S. GAAP operating income as a percentage of revenue of 30.2%, and U.S. GAAP diluted EPS of $5.59.
* Non-GAAP gross margin of 47.5%, non-GAAP operating income as a percentage of revenue of 31.1%, and non-GAAP diluted EPS of $5.67.

[https://www.unhedged.com/companies/5c548a24453c8c631e62db0b/\_/pressreleases/5f90948a4d85c29365ca4307/](https://www.unhedged.com/companies/5c548a24453c8c631e62db0b/_/pressreleases/5f90948a4d85c29365ca4307/)",2020-10-21,2,2
jdgti8_LRCX,LRCX,TER and LRCX Earnings play,"To keep this short because I am too lazy to write DD.

TER is a AI computer that specializes in Semiconductor testing and robots that Qualcomm, IBM, Samsung, uses.

LRCX is a semiconductor equipment maker.

&#x200B;

Both have showed good revenue growth and their markets are growing. I believe these will be record quarterly profits. Both companies are not overvalued and look like it will rip higher.

NOTE: I am not a pro and smarter people than I should comment.

Both are not mentioned on this sub as expected, because soon TSLA fanboys will come back and spam TSLA calls.

Note: my old main account made advice to buy LRCX when it was 320ish and now its 360.

# Postions: TER 11/20 80C

LRCX 11/20 360C

# DISCLAIMER: If you lose money do not kill me please and thanks.

Give your thoughts down below.",2020-10-18,1,9
itx2e2_LRCX,LRCX,Why i yolo'd into LRCX and you should to,,2020-09-16,8,11
gpu350_LRCX,LRCX,Unusual Options Activity for Lam Research $LRCX,,2020-05-24,18,49
gnilsr_LRCX,LRCX,OBVIOUSLY OVERPRICED PT.2: Lam Research (LRCX),"Original post: [https://www.reddit.com/r/wallstreetbets/comments/gbx209/first\_trade\_retards/](https://www.reddit.com/r/wallstreetbets/comments/gbx209/first_trade_retards/)

2nd post:  [https://www.reddit.com/r/wallstreetbets/comments/gjsv65/obviously\_overpriced\_lam\_research\_lrcx/](https://www.reddit.com/r/wallstreetbets/comments/gjsv65/obviously_overpriced_lam_research_lrcx/) 

&#x200B;

Looks like my favorite baby is on another run-up-followed-by-a-selloff cycle. I didn't buy calls when it dropped from 276 to 250 because I'm a pussy and thought it was too high. That's ok, now's a great time to buy puts. Will be back below 260 before end of week.

 

LRCX 250 p 6/19

LRCX 240 p 6/19

LRCX 230 p 6/26",2020-05-20,0,5
gjsv65_LRCX,LRCX,OBVIOUSLY OVERPRICED: Lam Research (LRCX),,2020-05-14,2,12
fvbmb8_LRCX,LRCX,ASML vs LRCX,,2020-04-05,1,3
d9mngk_LRCX,LRCX,$LRCX PUTS,,2019-09-26,12,15
cshzam_LRCX,LRCX,"Lam Research, LRCX. What am I missing?","Lam Research, LRCX seems like an excellent company to be a shareholder of. Here is a recent article for folks unfamiliar with the company: https://www.thestreet.com/investing/stocks/lam-research-outperformance-should-continue-15042982. 
Am I missing anything? As a shareholder, I fear I have rose colored glasses and want to see what others are seeing.",2019-08-19,14,10
cke0dq_LRCX,LRCX,Lam Research LRCX Earnings,So are we all bullish on semis again?,2019-07-31,1,1
aj3f4y_LRCX,LRCX,$LRCX Earnings Thread,"Estimated EPS: $3.66

Estimated Revenue: $2.5 Billion


Actual EPS: $3.87

Actual Revenue: $2.52

Source: https://finance.yahoo.com/quote/LRCX

Link to Lam Research's Investor Relations Page: https://investor.lamresearch.com/investor-relations",2019-01-23,22,39
a6vjkm_LRCX,LRCX,Short $LRCX even further? Their CEO had to resign for â€˜workplace misconductâ€™ and I found a glassdoor review claiming pattern sexual advancing at work,,2018-12-17,18,10
a3h8ci_LRCX,LRCX,LRCX CEO resigns,,2018-12-05,7,10
9j8ovl_LRCX,LRCX,Is LRCX a buy for the long term?,Is this a buy for the long term or should I wait for it to possibly go down more? I'm already holding AMAT for the long term.,2018-09-27,2,5
9gbl9r_LRCX,LRCX,NEW BUY: LRCX 50% UPSIDE,"LRCX closed near $153.50 on Friday.  The company has seen a few downgrades from Wall St analysts, most notably Goldman Sachs and Bank of America.   They expect memory capex to be soft in 2019 and perhaps beyond.   LRCX  has one of the best management teams in the industry and we think there is 50% upside from current levels. 

The stock is down from $230 March of this year.   The stock bottomed near these levels in February and could see a strong rebound again into the end of year.  ",2018-09-16,0,3
99ji1b_LRCX,LRCX,What do you all think about Lam Research (LRCX) and itâ€™s role in the semiconductor industry?,,2018-08-23,1,2
925xvz_LRCX,LRCX,Why is LRCX down after the earnings reports?,The reported EPS is higher than what was anticipated. Like what the hell?,2018-07-26,1,8
926oe8_LRCX,LRCX,LRCX spiking. Buy that and NVDA now bois.,Gottaâ€™ make that FB money back.  Had fun trading AMZN after hours but it doesnâ€™t look like a big winner for Friday.  Semis might catch bid now. ,2018-07-26,8,22
8x2q6l_LRCX,LRCX,More upside with MU or LRCX?,"I'm planning to add to each of these positions in the next couple days. Anyone else? If so, do you have a preference and why?",2018-07-08,8,6
8wy9va_LRCX,LRCX,Somebody tell me where LRCX is headed,And hold my hand,2018-07-08,7,14
8w9ncz_LRCX,LRCX,Lam Research ($LRCX),"The fundamentals on Lam Research still show it is a quality stock, more so now that is 25 bucks cheaper. \*I am now over 15&#37; in the red since buying around $200/share. 

The news has been negative and trade issues have made this one pullback. What are other's thoughts on $LRCX?",2018-07-05,27,11
8w351u_LRCX,LRCX,Anyone following $LRCX? Let's talk value and earnings....,,2018-07-04,1,6
8sjwzj_LRCX,LRCX,Is LRCX screwed if MU tanks???,,2018-06-20,4,11
8s0hla_LRCX,LRCX,What's up with LRCX?,,2018-06-18,3,4
8r4kas_LRCX,LRCX,LRCX a huge buy?,Most analysts are putting target price at $200-$300 and its trading at $181.x today. Think it's a good buy?,2018-06-14,16,27
8q9x7b_LRCX,LRCX,$LRCX deep sea exploration,,2018-06-11,19,16
8pf6rk_LRCX,LRCX,Went dip buying today on margin/balance transfers ($AMAT and $LRCX),,2018-06-07,7,14
8pacy9_LRCX,LRCX,$LRCX in free Fall,Down 5% on no news?,2018-06-07,16,21
8pap3b_LRCX,LRCX,Whats going on with Lam Research ($LRCX) today? Currently down about 7% today alone.,"Caption. Earnings are very solid, they have beaten expectations yet again. Is there a particular reason this is declining That I didn't see? I do not have a position currently but I want one soon.",2018-06-07,4,9
8mjk8t_LRCX,LRCX,Lam Research (LRCX),,2018-05-27,6,13
8echvu_LRCX,LRCX,"LRCX is green, AAPL is green, MU is -2% red.",,2018-04-23,31,14
8djylj_LRCX,LRCX,Who else is catching the LRCX knife with me?,,2018-04-20,18,12
8d11a8_LRCX,LRCX,Lam Research (LRCX) down 7% after hours with good earnings report and guidance. Why???,I'm fairly new to investing so maybe there is something I am missing but why did this stock sink like a rock after they reported earnings? They beat estimates $4.79 to $4.38 eps. From what I read they are very upbeat about their growth and future revenues and earnings. It's still plenty off the recent high of $228 on March 12th. Why the free fall?? I do have a position FYI.,2018-04-17,5,27
8czmsd_LRCX,LRCX,$LRCX beats on everything. Down 3% AH,,2018-04-17,13,14
8czfg6_LRCX,LRCX,LRCX ER hype thread,,2018-04-17,8,18
8csum8_LRCX,LRCX,LRCX FD first thing tomorrow morning?,"Iâ€™m tempted to buy the cheapest call above strike price exp Friday. I have a feeling it will beat earnings and go up 3-5%.
Premium is $4.15, so somewhat pricey.
My question: Is this a stupid move?",2018-04-17,4,10
8czob1_LRCX,LRCX,"LRCX Q3 - $4.79 vs. $4.38 - beats on rev, margin, earnings, top end of range for guidance on Q4 annndddd rolls -3% in after hours.",,2018-04-17,47,36
82trxv_LRCX,LRCX,Lam Research (LRCX) vs Micron (MU) - Which would you buy?,Would really appreciate any ideas about these companies. ,2018-03-08,0,1
82trx9_LRCX,LRCX,Lam Research (LRCX) vs Micron (MU) - Which would you buy?,,2018-03-08,6,3
82tmvk_LRCX,LRCX,Lam Research (LRCX) vs Micron (MU) - Which is better and why?,,2018-03-08,7,14
82ts0e_LRCX,LRCX,Lam Research (LRCX) vs Micron (MU) - Which would you buy?,Would really appreciate any ideas about these companies. ,2018-03-08,3,13
82fuav_LRCX,LRCX,$lrcx,I've got 1 call of lrcx at 210 expires 6/15 that is up +275% for 1k.  I bought the dip at 165 - obviously wishing I went all in now but I'm wondering if I should call it a win and sell or do you think there is still room to grow in the near future,2018-03-06,7,5
81kh6y_LRCX,LRCX,Something I noticed about LRCX Options,"I own the 3/29 215 calls & the April 20 215 calls.
Over the past couple days, Iâ€™ve noticed something strange, and I think itâ€™s due to a slight illiquidity in the options but Iâ€™m not sure. Basically during different times of these days, LRCX was at the same price, but the value of my contracts was drastically different. 

Ex. LRCX @ $191.00

April 20 215 calls are worth $4.00 at one time, and 3.20$ at another.

Is this due to illiquidity or something else?",2018-03-03,7,4
7w5mo2_LRCX,LRCX,"Semiconductor Eqmt & Materials ($LRCX, $AMAT, etc) are getting pummeled.",,2018-02-08,8,11
7u4utq_LRCX,LRCX,What is up with Lam Research,"The company topped its earnings and guidance for this quarter but the company's stock has taken a hit the past couple of days. I don't have a position in it but do with Applied Materials, which has some correlation with it, both being semi conductor companies. Any insight to why it's down? Is this just a cycle?",2018-01-30,2,5
7sx3ul_LRCX,LRCX,I don't understand LRCX,,2018-01-25,9,7
7syw47_LRCX,LRCX,RIP LRCX and thanks for the tendies,,2018-01-25,11,8
7sx3ul_KLAC,KLAC,I don't understand LRCX,,2018-01-25,8,7
7sp54x_LRCX,LRCX,Thoughts on $LRCX earnings report?,,2018-01-24,6,24
7sqm6m_LRCX,LRCX,Lrcx beat 4.34 eps vs 3.67 eps. Rev 2.58 bil vs 2.57bil,Good news Mu wonâ€™t drop. Sk Hynix you are our only hope,2018-01-24,39,36
7ql3ew_LRCX,LRCX,Investing Opportunity - LRCX,,2018-01-15,0,5
7ql3ew_KLAC,KLAC,Investing Opportunity - LRCX,,2018-01-15,0,5
77rask_LRCX,LRCX,What do yâ€™all think about LRCX?,I have serious FOMO.,2017-10-21,3,4
73cb4n_LRCX,LRCX,Three years ago I bought Lam Research (LRCX) at $74; I am a happy man.,,2017-09-30,1,14
6wtfuo_LRCX,LRCX,"LRCX, AVGO, AMAT, NVDA, or MU?",Favorite semiconductor company right now? ,2017-08-29,16,12
6wtfuo_AVGO,AVGO,"LRCX, AVGO, AMAT, NVDA, or MU?",,2017-08-29,16,12
6shp89_LRCX,LRCX,LRCX moving into a new direction,"As i read today's post i thought it might be worth sharing for some LRCX holders. I will def continue holding them because i believe reaching the 200 is soon possible with the current milestone achievement.

&nbsp;

----

&nbsp;

Lam today announced it will provide funding and share its expertise in nanoscale technology and advanced systems engineering to support the goal of building a clinical DNA sequencer with the simplest workflow in the industry. The strategic collaboration with NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, will help develop NanoStringâ€™s proprietary next-generation DNA sequencing platform.
 
&nbsp;

The objectives of the collaboration are to complete the development of the Hyb & Seqâ„¢ (Hybridization and Sequencing)
single-molecule sequencing chemistry, design and engineer a clinical sequencing instrument, develop clinical assay panels, and secure the necessary regulatory approvals. In addition, the companies intend to explore methods for coupling the sequencing chemistry with advanced semiconductor fabrication processes to optimize the performance of molecular profiling platforms.
 
&nbsp;

â€œWe are excited to collaborate with NanoString to advance the development of their novel Hyb & Seq system and chemistry to meet the challenge of increasing our understanding of human genetics, and we envision a number of strategic benefits by aligning our complementary respective strengths,â€ said Martin Anstice, president and CEO, in the public announcement. â€œThis is a compelling opportunity for the whole to be significantly greater than the sum of its parts; it is an accelerator of enablement and value for both companies.â€
 
&nbsp;

DNA sequencing has begun revolutionizing medicine; however, its full potential can only be reached when the technology is simple enough for a small hospital or clinic to use. The Hyb & Seq platform is uniquely qualified to serve a small lab, delivering a simpler workflow and faster turnaround time with an improved cost of ownership. The proprietary NanoString chemistry is compatible with any clinical sample and enables access to a broad range of critical information for clinicians, paving the way for a new era in health care.
 
&nbsp;

Over the past two years, the Lam senior leadership team has considered where the companyâ€™s core competencies could be leveraged to create new opportunities capable of delivering long-term value to all stakeholders. The DNA sequencing market was selected as one of these opportunities because it is a substantive, high-growth market with the potential for long-term disruption. Lamâ€™s core competencies â€“ such as nanoscale applications enablement, chemistry, plasma, fluidics, advanced systems engineering, and expertise in manufacturing and supply chain â€“ can add significant value in developing systems for this market. The NanoString collaboration is an opportunity to extend Lamâ€™s technology leadership in a new direction.
 
&nbsp;

â€œWe are excited to collaborate with Lam Research in a partnership that brings together leading innovators in our respective fields,â€ said Brad Gray, NanoString president and CEO. â€œBy combining our Hyb & Seq technology with Lamâ€™s advanced engineering expertise, we intend to fully resource the development of the industryâ€™s simplest clinical sequencer and enable open-ended innovation at the intersection of semiconductors and genomics.â€",2017-08-09,1,0
6k2wzm_LRCX,LRCX,LRCX,,2017-06-28,0,1
6iy1nh_LRCX,LRCX,LRCX compared to other similar companies?,,2017-06-23,1,1
6chxvp_LRCX,LRCX,Thoughts on $LRCX? This company has been on a tear this year.,,2017-05-21,2,4
62bwdo_KLAC,KLAC,"Thoughts? Also have 1k each in SOXL, KLAC, LRCX and 500 in ZYNE",,2017-03-30,5,2
62bwdo_LRCX,LRCX,"Thoughts? Also have 1k each in SOXL, KLAC, LRCX and 500 in ZYNE",,2017-03-30,3,2
3qpxqz_KLAC,KLAC,Lam Research (LRCX) Acquisition of KLA Tencor (KLAC) Concern,"It seems as though Lam has been one of the hot picks in the semiconductor industry since the announcement of its acquisition of KLA Tencor. With AMAT declining, the company is likely poised to challenge for the #1 spot in the semiconductor equipment and materials subset of semiconductors. As Lam and KLA service the same clients, but at different stages of the manufacturing process, the deal expands the breadth of Lam's product line while utilizing already-in-place customer relations and supply routes.

That being said, I'm incredibly concerned with their new debt levels after the deal goes through. While Lam's debt position was favorable before the acquisition (around $1.9B in debt with $4.33B in cash and shareholder equity value of $5.1B), KLAC raised $2.75B in debt for a special dividend a year ago, which puts their total debt around $3.2B. This lowered their shareholder equity value to a pitiful $421M, and their $2.27B in cash, while significant, is not favorable by comparison. Lam guaranteed all of the senior notes owned by KLAC, so this debt is transferable, correct? All of this would be manageable were it not for the financing of the acquisition. Lam is financing the move through $1.9B in cash (cancelling out all but $370M of cash gained from KLAC) and $3.9B in debt raised. Post-merger, Lam will have around $4.5B in cash, and a whopping $9B in debt. Assuming Lam only transfers assets and the aforementioned LT debt from KLA Tencor (not acquiring KLAs other liabilities), the combined company's shareholder equity value could be well under $1B. For a company with a market cap of 12B, $9B in debt with a shareholder equity value under $1B is concerning, although the $4.5B in cash is attractive. 

Can anyone shed any light on my thought process here? Am I missing something? Perhaps LRCX guaranteeing the senior notes of KLAC doesn't mean the entire debt schedule of KLA Tencor transfers? Or are analysts simply not worried about those debt levels? I've had trouble finding anyone with negative views.",2015-10-29,5,5
3qpxqz_LRCX,LRCX,Lam Research (LRCX) Acquisition of KLA Tencor (KLAC) Concern,,2015-10-29,6,5
1pocb5_LRCX,LRCX,"Top buy stocks for Sep.25 : GT, GTAT, LRCX, OMX, RFMD â€¦",,2013-11-01,0,0
